Market Cap 308.84M
Revenue (ttm) 114.20M
Net Income (ttm) 120,000.00
EPS (ttm) N/A
PE Ratio 2.12
Forward PE N/A
Profit Margin 0.11%
Debt to Equity Ratio -0.15
Volume 790,400
Avg Vol 5,072,138
Day's Range N/A - N/A
Shares Out 45.02M
Stochastic %K 4%
Beta 1.38
Analysts Strong Sell
Price Target $15.75

Company Profile

Agenus Inc., a clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally. It offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, a programmed death receptor-1 (PD-1) blocking antibody; AGE...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 674 4400
Fax: 781 674 4200
Address:
3 Forbes Road, Lexington, United States
2_logs_higher
2_logs_higher Sep. 11 at 11:37 PM
$AGEN fwiw, for those of you who can read French
1 · Reply
Overcrumb
Overcrumb Sep. 11 at 9:31 PM
$AGEN Angelo de Claro has been named director of the FDA Oncology Center of Excellence. Project Front Runner : initiative toward having discussions with sponsors about moving clinical trials into the frontline or earlier disease settings. Agenus recently scrapped it’s late stage CRC phase 3 for a phase 3 frontline/adjuvant setting. Interesting….
1 · Reply
2_logs_higher
2_logs_higher Sep. 11 at 9:20 PM
$AGEN S-3 more flim flam https://d18rn0p25nwr6d.cloudfront.net/CIK-0001098972/a9635a96-2a01-48d9-9540-47a209f5e7be.pdf
2 · Reply
Brianrudi_
Brianrudi_ Sep. 11 at 7:16 PM
$AGEN hahahahaha! Losers!
0 · Reply
neversurrender2024
neversurrender2024 Sep. 11 at 5:19 PM
$AGEN to be or not to be.... these dummies posting advice dont even know who is running the company....LOL https://oncodaily.com/career/43361
0 · Reply
pedmac2000
pedmac2000 Sep. 11 at 4:58 PM
$AGEN @2_logs_higher @Magic_Eight_Ball_Says It’s taking for ever I agree But he did say months not years ( what did that mean ) Hope that the compassionate use and payer use over seas gets enough attention that a regulatory commission decides to speed things up He mentioned UK Belgium , Brazil , Argentina In addition to France Maybe try Saudi’s and uae where they can afford it The real trial should be called “The Joker “ The riddler ? Or my favorite The Penguin
0 · Reply
2_logs_higher
2_logs_higher Sep. 11 at 4:30 PM
$AGEN fwiw, promoting from within
1 · Reply
2_logs_higher
2_logs_higher Sep. 11 at 4:00 PM
$AGEN replay of the bag holders meeting fwiw
1 · Reply
neversurrender2024
neversurrender2024 Sep. 11 at 3:41 PM
$AGEN last time garo said months away 3 months later you got the fda rejection and a 50% haircut.....LOL!
0 · Reply
Hellaofagirl
Hellaofagirl Sep. 11 at 3:33 PM
$AGEN If this level fails to hold, which it wont, it’s going to go down like a lead balloon! Can easily shed 40% once it breaks down….. you have been warned! Anytime Garo speaks in an attempt to pump the shares its the kiss of death for shareholders.
2 · Reply
Latest News on AGEN
Agenus Registration statement: Registration filing

Sep 11, 2026, 8:00 AM EDT - 13 hours ago

Agenus Registration statement: Registration filing


Agenus Transcript: Investor update

Sep 10, 2026, 4:30 PM EDT - 1 day ago

Agenus Transcript: Investor update


Agenus Slides: Corporate presentation

Sep 2, 2026, 7:00 AM EDT - 9 days ago

Agenus Slides: Corporate presentation


Agenus Registration statement: Registration filing

Aug 7, 2026, 8:00 AM EDT - 5 weeks ago

Agenus Registration statement: Registration filing


Agenus Earnings release: Q2 2026

Aug 6, 2026, 9:30 AM EDT - 5 weeks ago

Agenus Earnings release: Q2 2026


Agenus Quarterly report: Q2 2026

Aug 6, 2026, 9:30 AM EDT - 5 weeks ago

Agenus Quarterly report: Q2 2026


Agenus reports Q2 revenue $34.5M vs $25.7M last year

2026-08-06T11:52:23.000Z - 5 weeks ago

Agenus reports Q2 revenue $34.5M vs $25.7M last year


Agenus Slides: Corporate presentation

Jul 30, 2026, 9:00 AM EDT - 6 weeks ago

Agenus Slides: Corporate presentation


Agenus price target raised to $14 from $8 at B. Riley

2026-07-30T12:37:16.000Z - 6 weeks ago

Agenus price target raised to $14 from $8 at B. Riley


Agenus Registration statement: Registration filing

Jul 20, 2026, 8:00 AM EDT - 7 weeks ago

Agenus Registration statement: Registration filing


Agenus files to sell 2.13M shares of common stock for holders

2026-07-20T10:10:56.000Z - 7 weeks ago

Agenus files to sell 2.13M shares of common stock for holders


Why Is Agenus (AGEN) Stock Up Today?

2026-07-13T16:51:30.000Z - 2 months ago

Why Is Agenus (AGEN) Stock Up Today?


Agenus price target raised to $30 from $23 at H.C. Wainwright

2026-07-13T16:20:13.000Z - 2 months ago

Agenus price target raised to $30 from $23 at H.C. Wainwright


Agenus Transcript: Investor update

Jul 13, 2026, 8:30 AM EDT - 2 months ago

Agenus Transcript: Investor update


Agenus Press release: Investor update

Jul 13, 2026, 8:30 AM EDT - 2 months ago

Agenus Press release: Investor update


Agenus Slides: Investor update

Jul 13, 2026, 8:30 AM EDT - 2 months ago

Agenus Slides: Investor update


Agenus announces $340M private placement

2026-07-13T10:05:12.000Z - 2 months ago

Agenus announces $340M private placement

LGND


Agenus reports three-year Phase 1b BOT+BAL data at ESMO GI

2026-07-06T11:35:16.000Z - 2 months ago

Agenus reports three-year Phase 1b BOT+BAL data at ESMO GI


Agenus Transcript: AGM 2026

Jun 16, 2026, 10:00 AM EDT - 2 months ago

Agenus Transcript: AGM 2026


Agenus Announces Virtual 2026 Annual Shareholders Meeting

Jun 2, 2026, 4:30 PM EDT - 3 months ago

Agenus Announces Virtual 2026 Annual Shareholders Meeting


Agenus announces publication of Phase 1b BOT+BAL data

2026-05-15T20:23:26.000Z - 3 months ago

Agenus announces publication of Phase 1b BOT+BAL data


Agenus Proxy statement: Proxy filing

May 13, 2026, 8:00 AM EDT - 4 months ago

Agenus Proxy statement: Proxy filing


Agenus reports Q1 revenue $33.7M vs. $24.1M last year

2026-05-11T14:42:15.000Z - 4 months ago

Agenus reports Q1 revenue $33.7M vs. $24.1M last year


Agenus provides 2026 strategic priorities

2026-05-11T14:38:34.000Z - 4 months ago

Agenus provides 2026 strategic priorities


Agenus Earnings release: Q1 2026

May 11, 2026, 9:30 AM EDT - 4 months ago

Agenus Earnings release: Q1 2026


Agenus Quarterly report: Q1 2026

May 11, 2026, 9:30 AM EDT - 4 months ago

Agenus Quarterly report: Q1 2026


Agenus Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 4 months ago

Agenus Proxy statement: Proxy filing


Agenus Proxy statement: Proxy filing

Apr 20, 2026, 8:00 AM EDT - 4 months ago

Agenus Proxy statement: Proxy filing


Agenus Transcript: AGM 2026

Mar 31, 2026, 4:30 PM EDT - 5 months ago

Agenus Transcript: AGM 2026


Agenus Annual report: Q4 2025

Mar 16, 2026, 9:30 AM EDT - 5 months ago

Agenus Annual report: Q4 2025


Agenus Earnings release: Q4 2025

Mar 16, 2026, 9:30 AM EDT - 5 months ago

Agenus Earnings release: Q4 2025


Agenus Transcript: Status update

Jan 28, 2026, 4:00 PM EST - 7 months ago

Agenus Transcript: Status update


Agenus to Host First 2026 Stakeholder Webcast

Jan 20, 2026, 6:24 PM EST - 7 months ago

Agenus to Host First 2026 Stakeholder Webcast


Agenus Quarterly report: Q3 2025

Nov 10, 2025, 9:30 AM EST - 10 months ago

Agenus Quarterly report: Q3 2025


Agenus Earnings release: Q3 2025

Nov 10, 2025, 9:30 AM EST - 10 months ago

Agenus Earnings release: Q3 2025


Agenus Transcript: Status Update

Oct 21, 2025, 4:00 PM EDT - 10 months ago

Agenus Transcript: Status Update


Agenus Slides: Corporate Presentation

Sep 8, 2025, 7:00 AM EDT - 1 year ago

Agenus Slides: Corporate Presentation


Agenus Transcript: Stakeholder Briefing

Aug 27, 2025, 4:00 PM EDT - 1 year ago

Agenus Transcript: Stakeholder Briefing


Agenus Earnings Call Transcript: Q2 2025

Aug 11, 2025, 4:00 PM EDT - 1 year ago

Agenus Earnings Call Transcript: Q2 2025


Agenus Quarterly report: Q2 2025

Aug 11, 2025, 4:00 PM EDT - 1 year ago

Agenus Quarterly report: Q2 2025


Agenus Earnings release: Q2 2025

Aug 11, 2025, 4:00 PM EDT - 1 year ago

Agenus Earnings release: Q2 2025


Agenus Announces Virtual Annual Shareholders Meeting

Jun 10, 2025, 1:30 PM EDT - 1 year ago

Agenus Announces Virtual Annual Shareholders Meeting


2_logs_higher
2_logs_higher Sep. 11 at 11:37 PM
$AGEN fwiw, for those of you who can read French
1 · Reply
Overcrumb
Overcrumb Sep. 11 at 9:31 PM
$AGEN Angelo de Claro has been named director of the FDA Oncology Center of Excellence. Project Front Runner : initiative toward having discussions with sponsors about moving clinical trials into the frontline or earlier disease settings. Agenus recently scrapped it’s late stage CRC phase 3 for a phase 3 frontline/adjuvant setting. Interesting….
1 · Reply
2_logs_higher
2_logs_higher Sep. 11 at 9:20 PM
$AGEN S-3 more flim flam https://d18rn0p25nwr6d.cloudfront.net/CIK-0001098972/a9635a96-2a01-48d9-9540-47a209f5e7be.pdf
2 · Reply
Brianrudi_
Brianrudi_ Sep. 11 at 7:16 PM
$AGEN hahahahaha! Losers!
0 · Reply
neversurrender2024
neversurrender2024 Sep. 11 at 5:19 PM
$AGEN to be or not to be.... these dummies posting advice dont even know who is running the company....LOL https://oncodaily.com/career/43361
0 · Reply
pedmac2000
pedmac2000 Sep. 11 at 4:58 PM
$AGEN @2_logs_higher @Magic_Eight_Ball_Says It’s taking for ever I agree But he did say months not years ( what did that mean ) Hope that the compassionate use and payer use over seas gets enough attention that a regulatory commission decides to speed things up He mentioned UK Belgium , Brazil , Argentina In addition to France Maybe try Saudi’s and uae where they can afford it The real trial should be called “The Joker “ The riddler ? Or my favorite The Penguin
0 · Reply
2_logs_higher
2_logs_higher Sep. 11 at 4:30 PM
$AGEN fwiw, promoting from within
1 · Reply
2_logs_higher
2_logs_higher Sep. 11 at 4:00 PM
$AGEN replay of the bag holders meeting fwiw
1 · Reply
neversurrender2024
neversurrender2024 Sep. 11 at 3:41 PM
$AGEN last time garo said months away 3 months later you got the fda rejection and a 50% haircut.....LOL!
0 · Reply
Hellaofagirl
Hellaofagirl Sep. 11 at 3:33 PM
$AGEN If this level fails to hold, which it wont, it’s going to go down like a lead balloon! Can easily shed 40% once it breaks down….. you have been warned! Anytime Garo speaks in an attempt to pump the shares its the kiss of death for shareholders.
2 · Reply
Hellaofagirl
Hellaofagirl Sep. 11 at 3:05 PM
$AGEN Well hows them there shares doing after the ”fireside chat” which was replete with the usual bs. It should have been a ” dumpster fire chat” Agenus is not going to get an AA anytime soon, company moves like a snail and ignores advice about how trials should be conducted. its business as usual and that means dumping your money down a giant hole, diluting and eventually yet another reverse split. Garos history is abysmal as evidenced by the performance of AGEN, MINK and PTIX the latter being a pink sheet junk stock. So his history alone should scare you, add the habitual lying and you should be running away. someone else will eat their lunch as they have many times in the past because Garo thinks he knows better than anyone, the FDA included. my new target $5.75
0 · Reply
JohnG8
JohnG8 Sep. 11 at 2:40 PM
$AGEN commodore has not sent Agenus a letter appointing the 2 board members they are allowed to appoint. Why? Perhaps they have gotten cold feet. Perhaps the selloff we are seeing is commodore trying to get out of their position without getting their asses handed to them. Anybody have any information I am lacking about the 2 commodore appointed board members?
3 · Reply
Overcrumb
Overcrumb Sep. 11 at 2:31 PM
$AGEN Agenus/Zydus deal: Zydus has exclusive rights to develop and sell Bot/Bal in India and Sri Lanka ( 1.5 billion people ). Agenus receives 5% of revenues. Has any information been released about progress of Bot/Bal in this area? A small % of a large population.
2 · Reply
jcilip
jcilip Sep. 11 at 2:29 PM
$AGEN Market opportunity for BOT/BAL in just MSS colon cancer is 7 Billion dollars. Other indications could point to a much higher number. Hang in there longs!
0 · Reply
joechuck71
joechuck71 Sep. 11 at 2:03 PM
$AGEN we agenus own 1.8 mil mink common shares looks like something is coming. Vol up
0 · Reply
joechuck71
joechuck71 Sep. 11 at 1:56 PM
$AGEN go to agenus site lesson to the investor meeting as well. We are in a strong place finally.
0 · Reply
joechuck71
joechuck71 Sep. 11 at 1:07 PM
$AGEN Play it ! fantastic https://sqps.onstreamsecure.com/origin/enliven/players/EnlivenPlayer.html?customerId=22&eventId=97149568&checkCompany=1&checkEmail=1&checkName=1
1 · Reply
joechuck71
joechuck71 Sep. 11 at 1:05 PM
$AGEN https://sqps.onstreamsecure.com/origin/enliven/players/EnlivenPlayer.html?customerId=22&eventId=97149568&checkCompany=1&checkEmail=1&checkName=1
0 · Reply
Disney1295
Disney1295 Sep. 11 at 12:19 PM
$AGEN This may be wishful thinking, but I could see Agenus having a Replimune like event. They had ongoing challenges with the FDA and eventually received AA for a patient population with a significant unmet need. Their stock traded at $1.50 on April 13. The stock is over $13 now.
1 · Reply
joechuck71
joechuck71 Sep. 10 at 10:27 PM
$AGEN i think one of the best highlights were when My Taylor made it very clear that no one is close to the point we are and also the clinical data. That was to put investors at ease about the so called competition article that help but us off the path to a new 52 week high but that will change after this call.
1 · Reply
pedmac2000
pedmac2000 Sep. 10 at 9:42 PM
$AGEN I must say to my very pleasant surprise this it the best Call I have eve heard from Agenus !!! I can’t believe I’m saying this !! Very profesional Tons of good information I had never heard before Even with my past Garo experience He said within next months not years !! I am buying more tomo !!! LFG Thanks to presenters today
3 · Reply
joechuck71
joechuck71 Sep. 10 at 9:40 PM
$AGEN we are winning the race. !!
1 · Reply